Insider Trading activities of Heartware Ltd insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Heartware Ltd since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Heartware Ltd since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Heartware Ltd since 2005. The reporting company's ticker symbol is HTWR. The reporting company's CIK number is 1389072.
The total value of stock buying since 2005 is $13,890,596.
The total value of stock sales since 2005 is $286,112,498.
The total value of stock option exercises since 2005 is $8,575,776.


Go to page:  1   2   3   4 

Table 2. Detailed insider stock purchases, sales, and option exercises of Heartware Ltd insiders (HTWR) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-03-11 Mcaree Peter F (SVP, CFO and Treasurer) Sale 465 93.71 43,575
2014-03-10 Hathaway David R (Chief Medical Officer) Sale 1,601 95.00 152,095
2014-03-10 Hathaway David R (Chief Medical Officer) Option Ex 299 18.08 5,405
2014-03-10 Schuermann James (SVP, Sales & Marketing) Sale 2,000 94.22 188,440
2014-03-10 Schuermann James (SVP, Sales & Marketing) Option Ex 2,000 23.79 47,580
2014-03-10 Larose Jeffrey (Chief Scientific Officer) Sale 5,018 93.56 469,484
2014-03-06 Mcaree Peter F (SVP, CFO and Treasurer) Option Ex 1,400 .00 0
2014-03-03 Larose Jeffrey (Chief Scientific Officer) Sale 2,179 93.36 203,442
2014-03-03 Larose Jeffrey (Chief Scientific Officer) Option Ex 2,179 15.61 34,014
2014-02-10 Yocher Robert E (SVP, Regulatory & Quality) Sale 428 94.57 40,475
2014-02-10 Knopf Lawrence J (General Counsel) Sale 714 94.61 67,551
2014-02-10 Schuermann James (SVP, Sales & Marketing) Sale 810 94.72 76,723
2014-02-10 Larose Jeffrey (Chief Scientific Officer) Sale 685 94.58 64,787
2014-02-10 Godshall Douglas Evan (President & Chief Exec Officer) Sale 2,428 94.57 229,615
2014-02-10 Mcaree Peter F (SVP, CFO and Treasurer) Sale 714 94.62 67,558
2014-02-07 Yocher Robert E (SVP, Regulatory & Quality) Option Ex 800 .00 0
2014-02-07 Knopf Lawrence J (General Counsel) Option Ex 1,400 .00 0
2014-02-07 Schuermann James (SVP, Sales & Marketing) Option Ex 1,600 .00 0
2014-02-07 Larose Jeffrey (Chief Scientific Officer) Option Ex 1,600 .00 0
2014-02-07 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 5,000 .00 0
2014-02-07 Mcaree Peter F (SVP, CFO and Treasurer) Option Ex 1,400 .00 0
2014-02-03 Larose Jeffrey (Chief Scientific Officer) Sale 2,179 98.64 214,936
2014-02-03 Larose Jeffrey (Chief Scientific Officer) Option Ex 2,179 15.31 33,360
2014-01-07 Larose Jeffrey (Chief Scientific Officer) Sale 15,342 100.00 1,534,200
2014-01-06 Knopf Lawrence J (General Counsel) Sale 861 97.50 83,947
2014-01-06 Harrison Seth Loring (Director) Sale 7,909 99.29 785,284
2014-01-02 Larose Jeffrey (Chief Scientific Officer) Sale 2,179 92.96 202,559
2014-01-02 Larose Jeffrey (Chief Scientific Officer) Option Ex 2,179 15.62 34,035
2013-12-23 Yocher Robert E (SVP, Regulatory & Quality) Sale 482 90.96 43,842
2013-12-23 Knopf Lawrence J (General Counsel) Sale 723 90.99 65,785
2013-12-23 Hathaway David R (Chief Medical Officer) Sale 602 91.03 54,800
2013-12-23 Schuermann James (SVP, Sales & Marketing) Sale 1,204 91.36 109,997
2013-12-23 Larose Jeffrey (Chief Scientific Officer) Sale 1,873 91.36 171,107
2013-12-23 Godshall Douglas Evan (President & Chief Exec Officer) Sale 4,333 91.36 395,841
2013-12-21 Yocher Robert E (SVP, Regulatory & Quality) Option Ex 1,000 .00 0
2013-12-21 Knopf Lawrence J (General Counsel) Option Ex 1,500 .00 0
2013-12-21 Hathaway David R (Chief Medical Officer) Option Ex 1,250 .00 0
2013-12-21 Schuermann James (SVP, Sales & Marketing) Option Ex 2,500 .00 0
2013-12-21 Larose Jeffrey (Chief Scientific Officer) Option Ex 4,375 .00 0
2013-12-21 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 9,000 .00 0
2013-12-20 Hathaway David R (Chief Medical Officer) Sale 609 91.94 55,991
2013-12-20 Hathaway David R (Chief Medical Officer) Option Ex 1,263 .00 0
2013-12-20 Schuermann James (SVP, Sales & Marketing) Sale 1,405 92.00 129,260
2013-12-20 Schuermann James (SVP, Sales & Marketing) Option Ex 2,917 .00 0
2013-12-20 Larose Jeffrey (Chief Scientific Officer) Sale 1,199 91.97 110,278
2013-12-20 Larose Jeffrey (Chief Scientific Officer) Option Ex 2,800 .00 0
2013-12-20 Godshall Douglas Evan (President & Chief Exec Officer) Sale 2,703 92.05 248,797
2013-12-20 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 5,613 .00 0
2013-12-18 Thomas Robert Bain (Director) Sale 6,942 92.27 640,538
2013-12-06 Thomas Robert Bain (Director) Sale 3,000 95.29 285,870
2013-12-04 Thomas Robert Bain (Director) Sale 2,500 95.54 238,850
2013-12-02 Larose Jeffrey (Chief Scientific Officer) Sale 2,179 96.39 210,033
2013-12-02 Larose Jeffrey (Chief Scientific Officer) Option Ex 2,179 15.94 34,733
2013-12-02 Godshall Douglas Evan (President & Chief Exec Officer) Sale 13,000 95.58 1,242,605
2013-12-02 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 13,000 35.06 455,780
2013-11-15 Godshall Douglas Evan (President & Chief Exec Officer) Sale 10,000 90.00 900,000
2013-11-15 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 10,000 35.92 359,200
2013-11-07 Larose Jeffrey (Chief Scientific Officer) Sale 2,179 85.44 186,173
2013-11-07 Larose Jeffrey (Chief Scientific Officer) Option Ex 2,179 16.65 36,280
2013-11-07 Godshall Douglas Evan (President & Chief Exec Officer) Sale 8,000 82.37 658,960
2013-11-07 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 3,000 36.64 109,920
2013-10-14 Godshall Douglas Evan (President & Chief Exec Officer) Sale 8,000 75.03 600,200
2013-10-14 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 3,000 36.44 109,320
2013-09-03 Larose Jeffrey (Chief Scientific Officer) Sale 2,179 78.86 171,835
2013-09-03 Larose Jeffrey (Chief Scientific Officer) Option Ex 2,179 15.70 34,210
2013-09-03 Godshall Douglas Evan (President & Chief Exec Officer) Sale 8,000 78.31 626,480
2013-09-03 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 3,000 34.54 103,620
2013-08-01 Schuermann James (SVP, Sales & Marketing) Sale 1,000 93.07 93,070
2013-08-01 Larose Jeffrey (Chief Scientific Officer) Sale 2,179 93.50 203,747
2013-08-01 Larose Jeffrey (Chief Scientific Officer) Option Ex 2,179 15.77 34,362
2013-08-01 Godshall Douglas Evan (President & Chief Exec Officer) Sale 18,000 94.74 1,705,320
2013-08-01 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 13,000 34.70 451,100
2013-07-31 Larkin C Raymond Jr (Director) Option Ex 564 .00 0
2013-07-29 Godshall Douglas Evan (President & Chief Exec Officer) Sale 7,530 92.64 697,541
2013-07-29 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 2,530 35.63 90,143
2013-07-26 Godshall Douglas Evan (President & Chief Exec Officer) Sale 12,834 93.29 1,197,283
2013-07-26 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 12,834 35.32 453,296
2013-07-25 Godshall Douglas Evan (President & Chief Exec Officer) Sale 12,636 93.63 1,183,108
2013-07-25 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 12,636 35.53 448,957
2013-07-10 Mcaree Peter F (SVP, CFO and Treasurer) Sale 2,950 93.58 276,061
2013-07-09 Mcaree Peter F (SVP, CFO and Treasurer) Option Ex 6,250 .00 0
2013-07-01 Harrison Seth Loring (Director) Sale 13,118 95.60 1,254,080
2013-07-01 Larose Jeffrey (Chief Scientific Officer) Sale 2,179 95.92 209,009
2013-07-01 Larose Jeffrey (Chief Scientific Officer) Option Ex 2,179 15.98 34,820
2013-06-26 Knopf Lawrence J (General Counsel) Sale 992 95.00 94,240
2013-06-25 Yocher Robert E (SVP, Regulatory & Quality) Sale 1,162 94.25 109,518
2013-06-23 Yocher Robert E (SVP, Regulatory & Quality) Option Ex 2,500 .00 0
2013-06-17 Larose Jeffrey (Chief Scientific Officer) Sale 2,179 91.14 198,594
2013-06-17 Larose Jeffrey (Chief Scientific Officer) Option Ex 2,179 16.74 36,476
2013-06-06 Thomas Robert Bain (Director) Sale 2,656 90.41 240,128
2013-05-30 Thomas Robert Bain (Director) Sale 57 94.05 5,360
2013-05-29 Thomas Robert Bain (Director) Sale 714 93.50 66,762
2013-05-28 Hathaway David R (Chief Medical Officer) Sale 5,934 95.05 564,026
2013-05-28 Hathaway David R (Chief Medical Officer) Option Ex 4,491 19.22 86,317
2013-05-28 Thomas Robert Bain (Director) Sale 2,786 93.02 259,145
2013-05-23 Thomas Robert Bain (Director) Sale 2,300 91.90 211,370
2013-05-22 Hathaway David R (Chief Medical Officer) Sale 2,400 95.15 228,360
2013-05-22 Hathaway David R (Chief Medical Officer) Option Ex 2,400 19.55 46,920
2013-05-21 Hathaway David R (Chief Medical Officer) Sale 17,140 96.31 1,650,753
2013-05-21 Hathaway David R (Chief Medical Officer) Option Ex 17,140 19.51 334,401
2013-05-21 Thomas Robert Bain (Director) Sale 200 97.69 19,538
2013-05-20 Knopf Lawrence J (General Counsel) Sale 2,000 97.72 195,440
2013-05-20 Hathaway David R (Chief Medical Officer) Sale 10,000 97.89 978,900
2013-05-20 Hathaway David R (Chief Medical Officer) Option Ex 10,000 19.40 194,000
2013-05-20 Wade Denis Newell (Director) Sale 4,000 99.00 396,000
2013-05-20 Thomas Robert Bain (Director) Sale 6,429 98.08 630,582
2013-05-20 Larose Jeffrey (Chief Scientific Officer) Sale 9,574 97.94 937,629
2013-05-12 Harrison Seth Loring (Director) Option Ex 250 .00 0
2013-05-12 Wade Denis Newell (Director) Option Ex 250 .00 0
2013-05-12 Stockman Robert Bernard (Director) Option Ex 250 .00 0
2013-05-12 Thomas Robert Bain (Director) Option Ex 250 .00 0
2013-05-12 Barberich Timothy J (Director) Option Ex 250 .00 0
2013-05-12 Larkin C Raymond Jr (Director) Option Ex 250 .00 0
2013-05-04 Harrison Seth Loring (Director) Option Ex 333 .00 0
2013-05-04 Wade Denis Newell (Director) Option Ex 333 .00 0
2013-05-04 Stockman Robert Bernard (Director) Option Ex 333 .00 0
2013-05-04 Thomas Robert Bain (Director) Option Ex 333 .00 0
2013-05-04 Barberich Timothy J (Director) Option Ex 333 .00 0
2013-05-04 Larkin C Raymond Jr (Director) Option Ex 333 .00 0
2013-05-01 Schuermann James (SVP, Sales & Marketing) Sale 1,000 97.20 97,200
2013-05-01 Harrison Seth Loring (Director) Option Ex 250 .00 0
2013-05-01 Wade Denis Newell (Director) Option Ex 250 .00 0
2013-05-01 Stockman Robert Bernard (Director) Option Ex 250 .00 0
2013-05-01 Thomas Robert Bain (Director) Option Ex 250 .00 0
2013-05-01 Feldmann Cynthia L (Director) Option Ex 500 .00 0
2013-05-01 Barberich Timothy J (Director) Option Ex 250 .00 0
2013-05-01 Larkin C Raymond Jr (Director) Option Ex 250 .00 0
2013-03-28 Knopf Lawrence J (General Counsel) Sale 2,500 88.75 221,887
2013-03-28 Knopf Lawrence J (General Counsel) Option Ex 5,250 .00 0
2013-02-01 Schuermann James (SVP, Sales & Marketing) Sale 1,000 90.59 90,590
2012-12-21 Yocher Robert E (SVP, Regulatory & Quality) Sale 426 81.97 34,921
2012-12-21 Yocher Robert E (SVP, Regulatory & Quality) Option Ex 1,000 .00 0
2012-12-21 Knopf Lawrence J (General Counsel) Sale 639 81.97 52,382
2012-12-21 Knopf Lawrence J (General Counsel) Option Ex 1,500 .00 0
2012-12-21 Hathaway David R (Chief Medical Officer) Sale 532 81.97 43,610
2012-12-21 Hathaway David R (Chief Medical Officer) Option Ex 1,250 .00 0
2012-12-21 Schuermann James (SVP, Sales & Marketing) Sale 1,064 81.98 87,226
2012-12-21 Schuermann James (SVP, Sales & Marketing) Option Ex 2,500 .00 0
2012-12-21 Larose Jeffrey (Chief Scientific Officer) Sale 1,627 81.98 133,381
2012-12-21 Larose Jeffrey (Chief Scientific Officer) Option Ex 4,375 .00 0
2012-12-21 Godshall Douglas Evan (President & Chief Exec Officer) Sale 3,829 81.97 313,882
2012-12-21 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 9,000 .00 0
2012-12-21 Farrell Lauren (VP, Finance) Sale 405 81.97 33,197
2012-12-21 Farrell Lauren (VP, Finance) Option Ex 1,250 .00 0
2012-12-20 Hathaway David R (Chief Medical Officer) Sale 537 82.09 44,082
2012-12-20 Hathaway David R (Chief Medical Officer) Option Ex 1,262 .00 0
2012-12-20 Schuermann James (SVP, Sales & Marketing) Sale 532 82.09 43,671
2012-12-20 Schuermann James (SVP, Sales & Marketing) Option Ex 1,250 .00 0
2012-12-20 Larose Jeffrey (Chief Scientific Officer) Sale 1,042 82.09 85,537
2012-12-20 Larose Jeffrey (Chief Scientific Officer) Option Ex 2,800 .00 0
Go to page:  1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of HTWR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Heartware Ltd (symbol HTWR, CIK number 1389072) see the Securities and Exchange Commission (SEC) website.